Japanese companies invited to invest in Indian Pharma, Medical Devices industry

Delhi: ​A webinar on 'Medical Devices and API sector: Challenges & Emerging Opportunities' was held for business and trade collaboration between India and Japan in the post-COVID-19 scenario. The webinar was organized by the Embassy of India, Tokyo in partnership with the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India.​

Mr Sanjay Kumar Verma, Ambassador of India to Japan shared his valuable thoughts on the golden opportunity for India and Japan to further boost their relationship in the context of the ongoing COVID-19 crisis. Dr P. D. Vaghela, Secretary, Pharmaceuticals presented the sectoral view and the investment opportunities in the pharmaceutical and medical device industry in India. He also presented various initiatives taken by the Government of India to promote trade and business in the country. Mr Navdeep Rinwa, Joint Secretary, Pharmaceuticals explained the Department's schemes to promote manufacturing of bulk drugs and medical devices viz. Production Linked Incentive schemes and Promotion of Bulk Drug/Medical Devices Parks and requested the delegates to avail benefits of the schemes.

Pharmaceutical Traders Association and Japan Federation of Medical Devices Associations deliberated on the Post COVID-19 challenges & opportunities for Pharmaceutical & Medical Device sectors and its impact on the global supply chain and suggested that cooperation between the two countries can contribute to stabilizing the supply-chain of especially APIs and Medical Devices. The representative of JETRO Chennai also shared insights on challenges and emerging opportunities in the API sector and Medical Devices.